Grifols, S.A. (GRFS)
NASDAQ: GRFS · Real-Time Price · USD
8.77
+0.07 (0.80%)
Jun 20, 2025, 4:00 PM - Market closed
Grifols Market Cap
Grifols has a market cap or net worth of $7.32 billion as of June 20, 2025. Its market cap has increased by 44.52% in one year.
Market Cap
7.32B
Enterprise Value
20.81B
1-Year Change
44.52%
Ranking
Category
Stock Price
$8.77
Market Cap Chart
Since June 2, 2011, Grifols's market cap has increased from $5.00B to $7.32B, an increase of 46.57%. That is a compound annual growth rate of 2.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 20, 2025 | 6.03B | 17.88% |
| Dec 31, 2024 | 5.12B | -35.64% |
| Dec 29, 2023 | 7.95B | 36.00% |
| Dec 30, 2022 | 5.84B | -24.31% |
| Dec 31, 2021 | 7.72B | -39.10% |
| Dec 31, 2020 | 12.68B | -20.82% |
| Dec 31, 2019 | 16.01B | 26.85% |
| Dec 31, 2018 | 12.62B | -19.90% |
| Dec 29, 2017 | 15.76B | 42.63% |
| Dec 30, 2016 | 11.05B | -0.80% |
| Dec 31, 2015 | 11.14B | -4.68% |
| Dec 31, 2014 | 11.69B | -0.94% |
| Dec 31, 2013 | 11.80B | 39.30% |
| Dec 31, 2012 | 8.47B | 134.45% |
| Dec 30, 2011 | 3.61B | -27.71% |
View and export this data all the way back to 2011.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 704.75B |
| Johnson & Johnson | 362.67B |
| Novo Nordisk | 333.14B |
| AbbVie | 327.65B |
| UnitedHealth Group | 278.67B |
| Abbott Laboratories | 230.37B |
| Novartis AG | 227.73B |
| AstraZeneca | 219.65B |